Genelux (GNLX) Operating Leases (2022 - 2026)
Genelux's (GNLX) quarterly Operating Leases came in at $2.2 million in Q1 2026, up 21.94% year-on-year from $1.8 million in Q1 2025, and up 73.21% quarter-over-quarter from $1.3 million in Q4 2025.
Genelux (GNLX) Operating Leases (2022 - 2026) Analysis & Trends
Genelux's Operating Leases history runs 5 years deep, the most recent figure standing at $2.2 million for Q1 2026.
- On a quarterly basis, Operating Leases rose 21.94% year-over-year to $2.2 million in Q1 2026; TTM through Mar 2026 was $2.2 million, a 21.94% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, down 18.26% from the prior year.
- Operating Leases grew to $2.2 million in Q1 2026 per GNLX's latest filing, from $1.3 million in the prior quarter.
- Across five years, Operating Leases topped out at $2.2 million in Q2 2024 and bottomed at $1.2 million in Q4 2022.
- The 5-year median for Operating Leases is $1.6 million (2024), against an average of $1.6 million.
- Across the five-year window, Operating Leases soared 60.31% in 2023 and sank 38.33% in 2025, its largest moves.
- Year by year, Operating Leases stood at $1.2 million in 2022, then jumped by 60.31% to $1.9 million in 2023, then fell by 17.52% to $1.5 million in 2024, then decreased by 18.26% to $1.3 million in 2025, then soared by 73.21% to $2.2 million in 2026.
- Per Business Quant, the three latest GNLX Operating Leases figures stand at $2.2 million (Q1 2026), $1.3 million (Q4 2025), and $1.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.18 Mn |
| Dec 31, 2025 | 1.26 Mn |
| Sep 30, 2025 | 1.27 Mn |
| Jun 30, 2025 | 1.36 Mn |
| Mar 31, 2025 | 1.79 Mn |
| Dec 31, 2024 | 1.54 Mn |
| Sep 30, 2024 | 1.62 Mn |
| Jun 30, 2024 | 2.21 Mn |
| Mar 31, 2024 | 1.79 Mn |
| Dec 31, 2023 | 1.87 Mn |
| Sep 30, 2023 | 1.29 Mn |
| Dec 31, 2022 | 1.16 Mn |